Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Interferon-alpha: a therapeutic target in systemic lupus erythematosus.

Rheumatic diseases clinics of North America - 1 Feb 2010

Crow Mary K

Abstract excerpt

The long history of elevated interferon (IFN)-alpha in association with disease activity in patients who have systemic lupus erythematosus (SLE) has assumed high significance in the past decade, with accumulating data strongly supporting broad activation of the type I IFN pathway in cells of pati...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoantibodies
Share to Interferon-alpha
Share to Lupus Erythematosus, Systemic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Polymorphism, Single Nucleotide

Source

Open in PubMed Open full text

Identifiers

PMID: 20202598
DOI: 10.1016/j.rdc.2009.12.008
PMCID: PMC2843146

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20202598-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Interferon-alpha: a therapeutic target in systemic lupus erythematosus.PMID 20202598Read ↗

Interferon alpha as a primary pathogenic factor in human lupus.Semantic proximity Read ↗

Optimal Selection of IFN-α-Inducible Genes to Determine Type I Interferon Signature Improves the Diagnosis of Systemic Lupus ErythematosusSemantic proximity Read ↗

Activation of type I interferon pathway in systemic lupus erythematosus: association with distinct clinical phenotypes.Semantic proximity Read ↗

Type I Interferons in Autoimmunity: Implications in Clinical Phenotypes and Treatment Response.Semantic proximity Read ↗

Interferon regulatory factors: critical mediators of human lupus.Semantic proximity Read ↗

Abnormalities of the type I interferon signaling pathway in lupus autoimmunity.Semantic proximity Read ↗

Systemic lupus erythematosus: all roads lead to type I interferons.Semantic proximity Read ↗

Targeting of type I interferon in systemic autoimmune diseases.Semantic proximity Read ↗

Recent insights into the role of innate immunity in lupusSemantic proximity Read ↗

Interferon pathway in SLE: one key to unlocking the mystery of the diseaseSemantic proximity Read ↗

Unraveling the Link between Interferon-α and Systemic Lupus Erythematosus: From the Molecular Mechanisms to Target TherapiesSemantic proximity Read ↗

IFN‐γ Mediates the Development of Systemic Lupus ErythematosusSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.